Insulin resistance and its association with the components of the metabolic syndrome among obese children and adolescents

Carlos Juárez-López, Miguel Klünder-Klünder, Patricia Medina-Bravo, Adrián Madrigal-Azcárate, Eliezer Mass-Díaz, Samuel Flores-Huerta, Carlos Juárez-López, Miguel Klünder-Klünder, Patricia Medina-Bravo, Adrián Madrigal-Azcárate, Eliezer Mass-Díaz, Samuel Flores-Huerta

Abstract

Background: Insulin resistance is the primary metabolic disorder associated with obesity; yet little is known about its role as a determinant of the metabolic syndrome in obese children. The aim of this study is to assess the association between the degree of insulin resistance and the different components of the metabolic syndrome among obese children and adolescents.

Methods: An analytical, cross-sectional and population-based study was performed in forty-four public primary schools in Campeche City, Mexico. A total of 466 obese children and adolescents between 11-13 years of age were recruited. Fasting glucose and insulin concentrations, high density lipoprotein cholesterol, triglycerides, waist circumference, systolic and diastolic blood pressures were measured; insulin resistance and metabolic syndrome were also evaluated.

Results: Out of the total population studied, 69% presented low values of high density lipoprotein cholesterol, 49% suffered from abdominal obesity, 29% had hypertriglyceridemia, 8% presented high systolic and 13% high diastolic blood pressure, 4% showed impaired fasting glucose, 51% presented insulin resistance and 20% metabolic syndrome. In spite of being obese, 13% of the investigated population did not present any metabolic disorder. For each one of the components of the metabolic syndrome, when insulin resistance increased so did odds ratios as cardiometabolic risk factors.

Conclusions: Regardless of age and gender an increased degree of insulin resistance is associated with a higher prevalence of disorders in each of the components of the metabolic syndrome and with a heightened risk of suffering metabolic syndrome among obese children and adolescents.

References

    1. Rivera Dommarco J, Shamah-Levy T, Villalpando Hernández S, González de Cossio T, Hernández Prado B, Sepúlveda J. Encuesta Nacional de Nutrición 1999. Estado nutricio de niños y mujeres en México. Cuernavaca Morelos México: Instituto Nacional de Salud Pública; 2001.
    1. Olaiz-Fernández G, Rivera-Dommarco J, Shamah-Levy T, Rojas R, Villalpando-Hernández S, Hernández-Avila M, Sepúlveda-Amor J. Encuesta nacional de salud y nutrición 2006. Cuernavaca Morelos México: Instituto Nacional de Salud Pública; 2006.
    1. Chiarelli F, Marcovecchio ML. Insulin resistance and obesity in childhood. Eur J Endocrinol. 2008;159(Suppl 1):S67–S74. doi: 10.1530/EJE-08-0245.
    1. Dandona P, Aljada A, Mohanty P. The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia. 2002;45(6):924–930. doi: 10.1007/s00125-001-0766-5.
    1. Peña AS, Wiltshire E, MacKenzie K, Gent R, Piotto L, Hirte C, Couper J. Vascular endothelial relates to body mass nonobese children and smooth muscle function index and glucose in obese and nonobese children. J Clin Endocrinol Metab. 2006;91(11):4467–4471. doi: 10.1210/jc.2006-0863.
    1. Radziuk J. Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab. 2000;85(12):4426–4433. doi: 10.1210/jc.85.12.4426.
    1. Flores-Huerta S, Klünder-Klünder M, Reyes-de-la-Cruz L, Santos JI. Increase in body mass index and waist circumference is associated with high blood pressure in children and adolescents in Mexico City. Arch Med Res. 2009;40(3):208–215. doi: 10.1016/j.arcmed.2009.02.009.
    1. Perichart-Perera O, Balas-Nakash M, Schiffman-Selechnik E, Barbato-Dosal A, Vadillo-Ortega F. Obesity increases metabolic syndrome risk factors in school-aged children from an urban school in Mexico City. J Am Diet Assoc. 2007;107(1):81–91. doi: 10.1016/j.jada.2006.10.011.
    1. Taksali SE, Caprio S, Dziura J, Dufour S, Calí AMG, Goodman R, Papademetris X, Burgert TS, Pierpont BM, Savoye M. High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype. Diabetes. 2008;57:367–371. doi: 10.2337/db07-0932.
    1. Burke V, Beilin LJ, Simmer K, Oddy WH, Blake KV, Doherty D, Kendall GE, Newnham JP, Landau LI, Stanley FJ. Predictors of body mass index and associations with cardiovascular risk factors in Australian children: a prospective cohort study. Int J Obes. 2005;29(1):15–23. doi: 10.1038/sj.ijo.0802750.
    1. Amemiya S, Dobashi K, Urakami T, Sugihara S, Ohzeki T, Tajima N. Metabolic syndrome in youths. Pediatr Diabetes. 2007;8(Suppl 9):48–54. doi: 10.1111/j.1399-5448.2007.00332.x.
    1. Zimmet P, Alberti G, Kaufman F, Tajima N, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S. The metabolic syndrome in children and adolescents. Lancet. 2007;369(9579):2059–2061. doi: 10.1016/S0140-6736(07)60958-1.
    1. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents. Findings from the third national health and nutrition examination survey. Circulation. 2004;110:2494–2497. doi: 10.1161/01.CIR.0000145117.40114.C7.
    1. Cruz ML, Goran MI. The metabolic syndrome in children and adolescents. Current Diabetes Reports. 2004;4:53–62. doi: 10.1007/s11892-004-0012-x.
    1. Rodriguez-Moran M, Salazar-Vazquez B, Violante R, Guerrero-Romero F. Metabolic syndrome among children and adolescents aged 10-18 years. Diabetes Care. 2004;27(10):2516–2517. doi: 10.2337/diacare.27.10.2516.
    1. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med. 2003;157(8):821–827. doi: 10.1001/archpedi.157.8.821.
    1. Messiah SE, Arheart KL, Luke B, Lipshultz SE, Miller TL. Relationship between body mass index and metabolic syndrome risk factors among US 8- to 14-year-olds, 1999 to 2002. J Pediatr. 2008;153(2):215–221. doi: 10.1016/j.jpeds.2008.03.002.
    1. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL. 2000 CDC growth charts for the United States: Methods and development. National Center for Health Statistics. Vital Health Stat. 2002;11(246)
    1. DeLong DM, DeLong ER, Wood PD, Lippel K, BM R. A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol. The Lipid Research Clinics Prevalence Study. JAMA. 1986;256(17):2372–2377. doi: 10.1001/jama.256.17.2372.
    1. National high blood pressure education program working group on high blood pressure in children and adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(Suppl 2):555–576. doi: 10.1542/peds.114.2.S2.555.
    1. Fernández JR, Redden DT, Pietrobelli A, Allison DL. Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr. 2004;145(4):439–444. doi: 10.1016/j.jpeds.2004.06.044.
    1. Daniels SR, Greer FR. Committee on Nutrition. Lipid screening and cardiovascular health in childhood. Pediatrics. 2008;122(1):198–208. doi: 10.1542/peds.2008-1349.
    1. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics. 2005;115(4):e500–503. doi: 10.1542/peds.2004-1921.
    1. García-Cuartero B, García-Lacalle C, Jiménez-Lobo C, González-Vergaz A, Calvo-Rey C, Alcázar-Villar MJ, Díaz-Martínez E. Índice HOMA y QUICKI, insulina y péptido C en niños sanos. Puntos de corte de riesgo cardiovascular. An Pediatr (Barc) 2007;66(5):481–490. doi: 10.1157/13102513.
    1. Lebovitz HE, Banerji MA. Point: Visceral adiposity is causally related to insulin resistance. Diabetes Care. 2005;28(9):2322–2325. doi: 10.2337/diacare.28.9.2322.
    1. Hirschler V, Maccallini G, Karam C, González C, Aranda C. Are girls more insulin-resistant than boys? Clin Biochem. 2009;42(10-11):1051–1056. doi: 10.1016/j.clinbiochem.2009.03.002.
    1. Kaplowitz PB, Slora EJ, Wasserman RC, Pedlow SE, Herman-Giddens ME. Earlier onset of puberty in girls: Relation to increased body mass index and race. Pediatrics. 2001;108(2):347–353. doi: 10.1542/peds.108.2.347.
    1. Brufani C, Tozzi A, Fintini D, Ciampalini P, Grossi A, Fiori R, Kiepe D, Manco M, Schiaffini R, Porzio O. Sexual dimorphism of body composition and insulin sensitivity across pubertal development in obese Caucasian subjects. Eur J Endocrinol. 2009;160(5):769–775. doi: 10.1530/EJE-08-0878.
    1. Aguilar-Salinas CA, Olaiz G, Valles V, Torres JMR, Perez FJG, Rull JA, Rojas R, Franco A, Sepulveda J. High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nationwide survey. J Lipid Res. 2001;42(8):1298–1307.
    1. Posadas-Sánchez R, Posadas-Romero C, Zamora-González C, Mendoza-Pérez E, Cardoso-Saldaña G, Yamamoto-Kimura L. Lipid and lipoprotein profiles and prevalence of dyslipidemia in Mexican adolescents. Metabolism: clinical and experimental. 2007;56(12):1666–1672.
    1. Decsi T, Molnar D. Insulin resistance syndrome in children. Pediatr Drugs. 2003;5(5):291–299.
    1. Jago R, Harrell JS, McMurray RG, Edelstein S, Ghormli LE, Bassin S. Prevalence of abnormal lipid and blood pressure values among an ethnically diverse population of eighth-grade adolescents and screening implications. Pediatrics. 2006;117:2065–2073. doi: 10.1542/peds.2005-1716.
    1. Mahley RW, Pepin J, Palaoglu KE, Malloy MJ, Kane JP, Bersot TP. Low levels of high density lipoproteins in Turks, a population with elevated hepatic lipase: high density lipoprotein characterization and gender-specific effects of apolipoprotein E genotype. J Lipid Res. 2000;41(8):1290–1301.
    1. Villarreal-Molina MT, Aguilar-Salinas CA, Rodríguez-Cruz M, Riaño D, Villalobos-Comparan M, Coral-Vazquez R, Menjivar M, Yescas-Gomez P, Königsoerg-Fainstein M, Romero-Hidalgo S. The ATP-Binding cassette transporter A1 R230C variant affects HDL cholesterol levels and BMI in the Mexican population. Diabetes. 2007;56(7):1881–1887. doi: 10.2337/db06-0905.
    1. Lichtenstein AH. Thematic review series: Patient-Oriented Research. Dietary fat, carbohydrate, and protein: effects on plasma lipoprotein patterns. J Lipid Res. 2006;47(8):1661–1667. doi: 10.1194/jlr.R600019-JLR200.
    1. Dixon LB, Sundquist J, Winkleby M. Differences in Energy, Nutrient, and Food Intakes in a US Sample of Mexican-American Women and Men: Findings from the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol. 2000;152(6):548–557. doi: 10.1093/aje/152.6.548.
    1. Flores-Huerta S, Acosta-Cázares B, Rendón-Macías ME, Klünder-Klünder M, Gutiérrez-Trujillo G. ENCOPREVENIMSS 2003, 2004 y 2005. 5. Consumo de alimentos saludables, o con riesgo para la salud, 2004. Rev Med Inst Mex Seguro Soc. 2006;44(Suppl 1):S63–S78.
    1. Sinaiko AR, Steinberger J, Moran A, Hong C-P, Prineas RJ, Jacobs DR Jr. Influence of insulin resistance and body mass index at age 13 on systolic blood pressure, triglycerides, and high-density lipoprotein cholesterol at age 19. Hypertension. 2006;48(4):730–736. doi: 10.1161/01.HYP.0000237863.24000.50.
    1. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities: The role of insulin resistance and the sympathoadrenal system. N Engl J Med. 1996;334(6):374–382. doi: 10.1056/NEJM199602083340607.
    1. Chen W, Srinivasan SR, Elkasabany A, Ellsworth DL, Boerwinkle E, Berenson GS. Combined effects of endothelial nitric oxide synthase gene polymorphism (G894T) and insulin resistance status on blood pressure and familial risk of hypertension in young adults: the Bogalusa Heart Study. Am J Hipertens. 2001;14(10):1046–1052. doi: 10.1016/S0895-7061(01)02192-6.
    1. Jolliffe CJ, Janssen I. Development of age-specific adolescent metabolic syndrome criteria that are linked to the Adult Treatment Panel III and International Diabetes Federation Criteria. J Am Coll Cardiol. 2007;49(8):891–898. doi: 10.1016/j.jacc.2006.08.065.
    1. Perez-Gomez G, Huffman FG. Risk factors for type 2 diabetes and cardiovascular diseases in Hispanic adolescents. J Adolesc Health. 2008;43(5):444–450. doi: 10.1016/j.jadohealth.2008.03.010.
    1. Marini MA, Succurro E, Frontoni S, Hribal ML, Andreozzi F, Lauro R, Perticone F, Sesti G. Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women. Diabetes Care. 2007;30(8):2145–2147. doi: 10.2337/dc07-0419.
    1. Dvorak RV, DeNino WF, Ades PA, Poehlman ET. Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women. Diabetes. 1999;48(11):2210–2214. doi: 10.2337/diabetes.48.11.2210.
    1. Bouhours-Nouet N, Dufresne S, de Casson FB, Mathieu E, Douay O, Gatelais F, Rouleau S, Coutant R. High birth weight and early postnatal weight gain protect obese children and adolescents from truncal adiposity and insulin resistance. Diabetes Care. 2008;31(5):1031–1036. doi: 10.2337/dc07-1647.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever